Dr Sameer Mistry is a member of the Audit and Risk Management Committee. Sameer is a senior industry physician leader with more than 18 years’ experience in pharmaceuticals, medical devices and consumer healthcare across multiple disease areas. He is currently Global Medical Lead, Early Drug Development at GSK, prior to which he held other senior roles at GSK and at Johnson & Johnson. Before joining the industry, Sameer was a doctor in the UK NHS and a qualified member of the Royal College of Surgeons of Edinburgh.
Dr Sameer Mistry
Latest news
-
LifeArc launches £40m research centres that will unlock new tests, treatments and cures for people living with rare diseases
Read more: LifeArc launches £40m research centres that will unlock new tests, treatments and cures for people living with rare diseases -
First-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases
Read more: First-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases -
New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya
Read more: New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya